Asana, Inc.
For the period ended Oct 31, 2025. Filed Dec 2, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Oct 31, 2025 · Filed Dec 2, 2025
ASAN$9.59-4.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Nine Months Ended October 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities | ||
| Net loss | $(156,811) | $(193,237) |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||
| Allowance for expected credit losses | 1,592 | 1,025 |
| Depreciation and amortization | 15,918 | 12,730 |
| Amortization of deferred contract acquisition costs | 20,805 | 19,189 |
| Stock-based compensation expense | 165,067 | 160,702 |
| Net accretion of discount on marketable securities | (1,717) | (4,646) |
| Non-cash lease expense | 13,688 | 13,528 |
| Impairment of long-lived assets | 30,716 | — |
| Amortization of discount on revolving credit facility and term loan issuance costs | 91 | 91 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | 14,376 | 20,610 |
| Prepaid expenses and other current assets | (24,711) | (15,852) |
| Other assets | 561 | (4,594) |
| Accounts payable | 2,609 | 4,610 |
| Accrued expenses and other liabilities | (4,836) | (11,408) |
| Deferred revenue | 2,326 | 10,920 |
| Operating lease liabilities | (16,903) | (14,598) |
| Net cash provided by (used in) operating activities | 62,771 | (930) |
| Cash flows from investing activities | ||
| Purchases of marketable securities | (161,077) | (166,628) |
| Maturities of marketable securities | 165,576 | 195,605 |
| Purchases of property and equipment | (2,604) | (4,064) |
| Capitalized internal-use software costs | (7,361) | (4,702) |
| Net cash (used in) provided by investing activities | (5,466) | 20,211 |
| Cash flows from financing activities | ||
| Repayment of term loan | (3,750) | (1,875) |
| Repurchases of common stock | (74,183) | (73,869) |
| Proceeds from exercise of stock options | 2,835 | 3,884 |
| Proceeds from employee stock purchase plan | 13,012 | 13,665 |
| Taxes paid related to net share settlement of equity awards | — | (5) |
| Net cash used in financing activities | (62,086) | (58,200) |
| Effect of foreign exchange rates on cash, cash equivalents, and restricted cash | 3,795 | (656) |
| Net decrease in cash, cash equivalents, and restricted cash | (986) | (39,575) |
| Cash, cash equivalents, and restricted cash | ||
| Beginning of period | 184,864 | 236,663 |
| End of period | $183,878 | $197,088 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - CONTINUED
| Nine Months Ended October 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets | ||
| Cash and cash equivalents | $183,470 | $196,772 |
| Restricted cash | 408 | 316 |
| Total cash, cash equivalents, and restricted cash | $183,878 | $197,088 |
| Supplemental cash flow data | ||
| Cash paid for income taxes | $2,904 | $3,776 |
| Supplemental non-cash investing and financing information | ||
| Purchase of property and equipment in accounts payable and accrued expenses and other current liabilities | $835 | $1,193 |
| Stock-based compensation expense capitalized for internal-use software | $5,243 | $3,299 |
| Repurchases of common stock in accrued expenses and other current liabilities | $— | $820 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.